Drugs News and Research

RSS

New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

Teva Pharmaceutical Industries Ltd. today announced that several new studies supporting the company's innovative central nervous system portfolio will be presented at the 62nd American Academy of Neurology Annual Meeting in Toronto, April 10-17, 2010.

8 Apr 2010

FDA warns false, misleading statements over "lipodissolve" drugs

The U.S. Food and Drug Administration today issued warning letters to six U.S. based medical spas and a company in Brazil for making false or misleading statements on their Web sites about drugs they claim will eliminate fat in a procedure called "lipodissolve," or for otherwise misbranding lipodissolve products.

8 Apr 2010

Intelligent Hospital Systems validates usage of ICU Medical's ChemoCLAVE Bag Spike with RIVA

IV Automation is becoming an increasingly comprehensive technology after medical device company Intelligent Hospital Systems validated ICU Medical Inc.'s ChemoCLAVE Bag Spike for use with RIVA (Robotic IV Automation System) - a self-contained unit for filling IV syringes and bags.

8 Apr 2010

Phase II clinical trial of Avastin and Tarceva in patients with glioblastoma multiforme

Patients suffering from recently diagnosed malignant brain tumors called glioblastoma multiforme or a rare variant called gliosarcoma may be eligible to participate in a Phase II clinical trial at Cedars-Sinai Medical Center that combines two innovative drugs.

8 Apr 2010

Transcendental Meditation may reduce symptoms of depression

The Transcendental Meditation- technique may be an effective approach to reduce symptoms of depression, according to two new studies to be presented at the 31st Annual Meeting of the Society of Behavioral Medicine in Seattle, Washington April 9th, 2010.

8 Apr 2010

Scientists discover how mechanical stress promotes new bone growth

For osteoporosis patients unable to exercise, help may be on the way. That's because scientists have discovered precisely how mechanical stress, such as exercise, promotes new bone growth. This opens the door to entirely new therapies that can trick bones into thinking they are getting a workout. The research report describing this advance is published online in The FASEB Journal.

8 Apr 2010

Today's opinions and editorials

From an economic perspective, health reform will fail if we can't sometimes push back against the try-anything instinct (David Leonhardt, 4/6).

8 Apr 2010

BeaconEquity.com releases investment report on Cell Therapeutics

BeaconEquity.com announces an investment report featuring biotech company Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

7 Apr 2010

Updates from Phase I/IIa clinical trial of DIABECELL treatment in insulin-dependent diabetics

Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, today provided a penultimate update regarding the three-year follow up of its Phase I/IIa clinical trial in Russia of its DIABECELL® treatment in insulin-dependent diabetics.

7 Apr 2010

Updated report analyzing approval rates at FDA published

Sagient Research Systems, a leading publisher of independent research for the financial services, institutional investment and corporate intelligence communities, recently published an updated report analyzing approval rates at the U.S Food and Drug Administration. According to its research service, BioMedTracker, the rate of drugs that were approved by the FDA in 2008 and 2009 has remained close to the historical low seen in 2007.

7 Apr 2010

Study demonstrates potential ability of Chronix serum DNA assays in diagnosis of breast cancer

Chronix Biomedical today announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis (MS). Chronix Biomedical uses proprietary technology to identify disease-specific genetic fingerprints based on the circulating DNA that is released into the bloodstream by damaged and dying cells.

7 Apr 2010

Concerns over safety and effectiveness of "natural" treatments for treating anxiety

In a broad-based review of studies focused on drugs that treat anxiety, a Saint Louis University doctor found no evidence supporting the use of so-called "natural" treatments in combating the effects of anxiety.

7 Apr 2010

StockPreacher.com: GenVec's revenues for 2009 decline by 8%

StockPreacher.com announces an investment report featuring GenVec Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

7 Apr 2010

Illumina launches VeraCode ADME Core Panel

Illumina, Inc. today announced the launch of its VeraCode ADME Core Panel designed to help researchers study genetic predispositions for differential drug response and adverse events. The VeraCode ADME Core Panel offers the most complete representation of the key biomarkers associated with drug absorption, distribution, metabolism and excretion (ADME) as standardized by pharmaceutical industry experts in the PharmADME Core List.

From Illumina, Inc. 7 Apr 2010

Conservatives claim that national insurance freeze will save NHS £200m

The Conservatives have claimed that a halt in the Labour planned rise in National Insurance (NI) could mean £200 million in savings for the NHS and provide doctors more power to choose which drugs especially those treating cancer are made available.

7 Apr 2010

Senator Grassley issues warning about 'phanton pharmacies' while Tampa officials arrest pharmacists on fraud charges

Senator Charles Grassley, R-Iowa, wrote a letter to Department of Health and Human Services Secretary Kathleen Sebelius this week saying federal officials have failed to stop the growing trend of "phantom pharmacies" that bill millions to Medicare in prescription drug costs then disappear, ABC News reports.

7 Apr 2010

MEDEC adopts revised, restated Code of Conduct on Interactions with Healthcare Professionals

Effective today MEDEC membership has adopted a revised and restated Code of Conduct on Interactions with Healthcare Professionals.

7 Apr 2010

ESC heart failure meeting encourages audience interaction

"Delegates attending the meeting will get real insights into what's new in heart failure," said Professor Stefan Anker, chairman of the Heart Failure Congress Scientific Committee. "In what's the biggest international stand-alone meeting dedicated to heart failure, there'll be lots of hot of the press news. The very fact that 12 late breaking clinical trial updates are being presented at the meeting demonstrates how bright the future is in heart failure."

7 Apr 2010

Has the NHS procured too many swine flu shots?

Britain’s National Health Service (NHS) has nearly 34 million unused swine flu vaccines at present due to a drop in the number of cases and these vaccinations. A total 44 million shots were procured. 3.8 million of these unused shots will be sent to Africa via the World Health Organization to help them. Of the rest, 10.6m is already with GPs who will be ready to act if more people entitled to the jab come forward. But the remaining 23.6m will be held in reserve.

7 Apr 2010

Guidant imposed criminal penalty over $296M for withholding cardioverter defibrillator failure information

Guidant LLC pleaded guilty today in St. Paul, Minn., before U.S. District Court Judge Donovan W. Frank to criminal violations of the Federal Food, Drug and Cosmetic Act, the Justice Department announced. The medical device manufacturer's admission of criminal wrongdoing is the result of a four-year investigation into Guidant's handling of short-circuiting failures of three models of its implantable cardioverter defibrillators: the Ventak Prizm 2 DR (Model 1861) and the Contak Renewal (Models H135 and H155).

7 Apr 2010

Drugs News and Research

New studies supporting Teva Pharmaceutical Industries' CNS portfolio to be presented at AAN 2010

FDA warns false, misleading statements over "lipodissolve" drugs

Intelligent Hospital Systems validates usage of ICU Medical's ChemoCLAVE Bag Spike with RIVA

Phase II clinical trial of Avastin and Tarceva in patients with glioblastoma multiforme

Transcendental Meditation may reduce symptoms of depression

Scientists discover how mechanical stress promotes new bone growth

Today's opinions and editorials

BeaconEquity.com releases investment report on Cell Therapeutics

Updates from Phase I/IIa clinical trial of DIABECELL treatment in insulin-dependent diabetics

Updated report analyzing approval rates at FDA published

Study demonstrates potential ability of Chronix serum DNA assays in diagnosis of breast cancer

Concerns over safety and effectiveness of "natural" treatments for treating anxiety

StockPreacher.com: GenVec's revenues for 2009 decline by 8%

Illumina launches VeraCode ADME Core Panel

Conservatives claim that national insurance freeze will save NHS £200m

Senator Grassley issues warning about 'phanton pharmacies' while Tampa officials arrest pharmacists on fraud charges

MEDEC adopts revised, restated Code of Conduct on Interactions with Healthcare Professionals

ESC heart failure meeting encourages audience interaction

Has the NHS procured too many swine flu shots?

Guidant imposed criminal penalty over $296M for withholding cardioverter defibrillator failure information

Drug Discovery - Second Edition eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News